Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2025-12-24 @ 11:17 PM
NCT ID: NCT02956356
Eligibility Criteria: Inclusion Criteria: * Obese volunteers (BMI \> 30kg/m2) * Otherwise healthy * Informed Consent as documented by signature (Appendix Informed Consent Form) Exclusion Criteria: * Food allergies, food intolerance * Evidence of relevant cardiovascular, pulmonary, renal, hepatic, pancreatic, gastrointestinal, metabolic, endocrinological, neurological, psychiatric or other diseases at screening * Chronic or clinically relevant acute infections * Clinically relevant abnormalities in chemical, haematological or any other laboratory parameters * Participation in drug trials within 2 months before start of the study * Neurological or psychiatric disease or drug or alcohol abuse, which would interfere with the subjects proper completion of the protocol assignment * Pregnancy: although no contraindication pregnancy might influence metabolic state. Women who are pregnant or have the intention to become pregnant during the course of the study are excluded. In female participants of childbearing age not using safe contraception (oral, injectable, or implantable contraceptives, or intrauterine contraceptive devices) a urine pregnancy test is carried out upon screening. * Antibiotic therapy within the last 3 months before inclusion * Substance abuse, alcohol abuse * Inability to follow procedures due to psychological disorders, dementia or insufficient * Knowledge of project language (German). * Participation in another study with investigational drug within the 30 days preceding and during the present study.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 55 Years
Study: NCT02956356
Study Brief:
Protocol Section: NCT02956356